Report ID |
125088 |
Drug Identification Number |
02377225 |
Brand name |
MOZOBIL |
Common or Proper name |
Mozobil |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
MARKETED |
Active Ingredient(s) |
PLERIXAFOR |
Strength(s) |
20MG |
Dosage form(s) |
SOLUTION |
Route of administration |
SUBCUTANEOUS
SUBCUTANEOUS |
Packaging size |
1 x 2.0ml |
ATC code |
L03AX |
ATC description |
IMMUNOSTIMULANTS |
Reason for shortage |
Other (Please describe in comments) |
Anticipated start date |
2020-12-04 |
Actual start date |
|
Estimated end date |
Unknown |
Actual end date |
2020-11-25 |
Shortage status |
Avoided shortage |
Updated date |
2020-11-25 |
Company comments |
production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |